Trials / Completed
CompletedNCT04807959
Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
A Retrospective Study to Evaluate the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,200 (actual)
- Sponsor
- 20Lighter · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A retrospective review of body composition outcomes of participants of a comprehensive visceral-fat focused anti-obesity program. Data from approximately 2000-2500 participants are expected to be included in the study.
Detailed description
This is a retrospective, multi-center clinical study to evaluate the efficacy of the 20Lighter comprehensive anti-obesity program in reducing body composition measures including body weight, body fat, visceral adiposity, intracellular fluid, and other metrics of interest. Anecdotal evidence on reductions of prescription medication, chronic health issues, and improvements in quality of life will be gauged via review of patient assessment forms and surveys.
Conditions
- Obesity
- Obesity, Morbid
- Obesity, Visceral
- Central Obesity
- Metabolic Disease
- Hypertension
- Dyslipidemias
- Type 2 Diabetes
- Visceral Obesity
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 20Lighter anti-obesity program | A customized expert supervised 3-phase program including non-invasive proprietary nutritional, behavioral, and physiological components. |
Timeline
- Start date
- 2016-10-27
- Primary completion
- 2018-10-01
- Completion
- 2018-10-09
- First posted
- 2021-03-19
- Last updated
- 2021-03-22
Source: ClinicalTrials.gov record NCT04807959. Inclusion in this directory is not an endorsement.